Migraine Impacts Patients Far Beyond Attacks
Migraine is often perceived primarily as a headache disorder in clinical settings, but its impact transcends the acute pain episodes. Many patients report cognitive impairments, often described as “brain fog,” reduced productivity, and lasting impairments even between attacks. This reality leads to significant challenges in daily life.
These interictal symptoms contribute to a phenomenon known as “presenteeism,” where individuals appear to be capable of working but are not functioning at full capacity. This can have profound individual and socio-economic repercussions.
Care Gaps: Many Patients Receive No Specific Therapy
Despite clear treatment recommendations, a significant number of patients remain undertreated. Evidence suggests that many resort only to over-the-counter analgesics, often avoiding the transition to migraine-specific therapies.
Even during medical consultations, guidelines are not always followed for acute treatments, revealing multiple barriers in the care continuum—from diagnosis to therapy decisions through to proper application.
Common Errors in Acute Treatment
A significant issue lies in the improper use of available medications. Common mistakes include:
- Delayed intake of acute medication,
- Insufficient dosing (e.g., taking half a tablet),
- Ineffective therapeutic sequences with no outcome (e.g., repeated use of ineffective analgesics).
Such errors can markedly undermine treatment efficacy and contribute to medications being perceived as “ineffective.” Therefore, patient education is a critical component of migraine management.
Triptan Failure is Clinically Relevant
Even with guideline-compliant use, substantial therapy issues persist. A significant portion of patients does not respond adequately to triptans or cannot tolerate them, with about one-quarter reporting inadequate efficacy.
Though switching between different triptans may be beneficial, the success rate declines with each new option attempted. Thus, there is an ongoing need for effective alternatives for this patient population.
New treatment principles, such as CGRP-targeted acute therapies, like Rimegepant and Atogepant, hold promise in addressing this care gap by specifically intervening in CGRP-mediated pain processing.
Medication Overuse as a Risk Factor for Chronicization
Another major issue is the overuse of acute medications. Using analgesics or triptans on more than 10 days per month raises the risk for medication overuse headache (MOH) and can lead to chronic migraines.
In contrast, current data indicates that gepants do not show MOH-associated risks with repeated acute use. Thus, limiting the frequency of conventional acute therapies remains a central focus in migraine care, while the same restrictions do not apply to gepants, based on current understanding.
Diagnostic Uncertainties and Access Barriers
In addition to therapeutic challenges, diagnostic issues also arise. Unclear or atypical symptom patterns result in migraine not always being recognized correctly. Misconceptions, such as the idea that migraines must be unilateral, complicate accurate diagnosis.
Furthermore, some patients avoid seeking medical help due to stigmatization, lack of education, or personal reservations.
When Should Therapy Escalation Occur?
In practice, decisions to escalate therapy often occur too late. Experts recommend adjusting treatment when:
- Acute medication is needed multiple times per week,
- The frequency of attacks increases,
- Functional limitations worsen.
In these scenarios, not only should acute therapy be optimized, but prophylactic treatment should also be considered.
Conclusion: Increased Structure and Education in Care Required
The management of migraine patients remains inadequate, despite available treatment options. Key challenges include:
- Delayed or missed diagnoses,
- Improper use of acute medications,
- Inadequate responses to standard therapies,
- Medication overuse risk.
Enhancing patient education, implementing structured therapy algorithms, and making timely therapy adjustments are vital to sustainably improving care for migraine sufferers.
